Alzamend Neuro Net Tangible Assets

Alzamend Neuro (ALZN) currently reports a net tangible assets of $5.8M as of July 2026. That compares with $5.3M in the prior-year period — up 8.6% year over year. Use the charts on this page to explore Alzamend Neuro's net tangible assets history and peer comparisons.

Alzamend Neuro's net tangible assets increased from $5.3M to $5.8M — a 8.6% year-over-year increase (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alzamend Neuro reported $5.8M in net tangible assets as of July 2026. That compares with $5.3M in the prior-year period — up 8.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $5.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alzamend Neuro, and consider following ALZN for alerts when major investors trade the stock.

Alzamend Neuro is classified in the Healthcare sector. On net tangible assets, it currently shows $5.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALZN with unrelated industries.